The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Sargramostim (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 17 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 17 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated